Michael E. Jung

21.0k total citations · 3 hit papers
377 papers, 13.6k citations indexed

About

Michael E. Jung is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Michael E. Jung has authored 377 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 249 papers in Organic Chemistry, 123 papers in Molecular Biology and 30 papers in Pharmacology. Recurrent topics in Michael E. Jung's work include Synthetic Organic Chemistry Methods (98 papers), Asymmetric Synthesis and Catalysis (85 papers) and Oxidative Organic Chemistry Reactions (43 papers). Michael E. Jung is often cited by papers focused on Synthetic Organic Chemistry Methods (98 papers), Asymmetric Synthesis and Catalysis (85 papers) and Oxidative Organic Chemistry Reactions (43 papers). Michael E. Jung collaborates with scholars based in United States, Germany and Canada. Michael E. Jung's co-authors include Grazia Piizzi, Mark A. Lyster, Jacquelyn Gervay, Dongwon Yoo, Chris Tran, Charles L. Sawyers, John Wongvipat, Samedy Ouk, Derek S. Welsbie and Derin C. D’Amico and has published in prestigious journals such as Science, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael E. Jung

373 papers receiving 13.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

2009 1.7k citations Chris Tran, Samedy Ouk et al. Science profile →
gem-Disubstituent Effect: Theoretical Basis and Synthetic Applications

2005 786 citations Michael E. Jung et al. profile →
Quantitative dealkylation of alkyl ethers via treatment with trimethylsilyl iodide. A new method for ether hydrolysis

1977 369 citations Michael E. Jung et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael E. Jung	7.6k	4.7k	1.8k	988	933	377	13.6k
Michaël Kahn	4.8k 0.6×	9.5k 2.0×	1.1k 0.6×	742 0.8×	2.7k 2.9×	179	16.2k
R. Kiplin Guy	3.5k 0.5×	4.6k 1.0×	649 0.4×	983 1.0×	2.5k 2.7×	186	9.9k
Yuichi Hashimoto	4.2k 0.6×	7.7k 1.6×	280 0.2×	1.0k 1.0×	1.6k 1.8×	534	15.0k
Christian Bailly	5.6k 0.7×	10.6k 2.3×	457 0.3×	1.5k 1.6×	3.1k 3.3×	520	17.4k
William A. Denny	8.4k 1.1×	12.4k 2.6×	917 0.5×	827 0.8×	4.3k 4.6×	600	21.1k
Alan C. Sartorelli	3.1k 0.4×	8.5k 1.8×	789 0.4×	478 0.5×	4.9k 5.2×	514	15.9k
S. Brøgger Christensen	2.4k 0.3×	5.0k 1.1×	288 0.2×	862 0.9×	595 0.6×	285	10.6k
Duane D. Miller	3.7k 0.5×	6.2k 1.3×	1.6k 0.9×	960 1.0×	1.4k 1.5×	407	13.7k
William Roush	12.7k 1.7×	6.6k 1.4×	263 0.1×	1.9k 1.9×	1.3k 1.3×	406	18.9k
K. C. Nicolaou	7.7k 1.0×	4.4k 0.9×	209 0.1×	1.9k 1.9×	1.7k 1.8×	156	11.7k

Countries citing papers authored by Michael E. Jung

Since Specialization

Citations

This map shows the geographic impact of Michael E. Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Jung more than expected).

Fields of papers citing papers by Michael E. Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Jung. The network helps show where Michael E. Jung may publish in the future.

Co-authorship network of co-authors of Michael E. Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Jung. A scholar is included among the top collaborators of Michael E. Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Jung. Michael E. Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jung, Michael E., et al.. (2024). DDDR-43. ERAS-801 IS A SELECTIVE BRAIN-PENETRANT EGFR INHIBITOR WITH IMPROVED ACTIVITY AGAINST EGFR EXTRACELLULAR DOMAIN-MUTANT GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii135–viii135. 1 indexed citations

Cascio, Duilio, Martin L. Phillips, Musleh M. Muthana, et al.. (2021). Insight into the molecular basis of substrate recognition by the wall teichoic acid glycosyltransferase TagA. Journal of Biological Chemistry. 298(2). 101464–101464. 3 indexed citations

Tsang, Jonathan, Gyudong Kim, Kingsley Chow, et al.. (2020). Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors. ACS Medicinal Chemistry Letters. 11(10). 1799–1809. 23 indexed citations

Vega, Mario I., Yijiang Shi, Patrick Frost, et al.. (2019). A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity. Molecular Cancer Therapeutics. 18(10). 1822–1831. 8 indexed citations

Poddar, Soumya, Edmund V. Capparelli, Ethan W. Rosser, et al.. (2019). Development and preclinical pharmacology of a novel dCK inhibitor, DI-87. Biochemical Pharmacology. 172. 113742–113742. 9 indexed citations

Getchell, Rodman G., Jihye Lee, Michael E. Jung, et al.. (2018). Broad-spectrum antiviral JL122 blocks infection and inhibits transmission of aquatic rhabdoviruses. Virology. 525. 143–149. 20 indexed citations

Micewicz, Ewa D., Kwanghee Kim, Keisuke S. Iwamoto, et al.. (2017). 4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues. PLoS ONE. 12(7). e0181577–e0181577. 13 indexed citations

Shi, Yijiang, Tracy R. Daniels‐Wells, Patrick Frost, et al.. (2016). Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells. Cancer Research. 76(19). 5822–5831. 19 indexed citations

Escamilla, Jemima, Shiruyeh Schokrpur, Saul J. Priceman, et al.. (2015). CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy. Cancer Research. 75(6). 950–962. 149 indexed citations

10.

Hong, Cynthia, Stephanie Marshall, Allison L. McDaniel, et al.. (2014). The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice. Cell Metabolism. 20(5). 910–918. 70 indexed citations

11.

Jacobitz, Alex W., Jeff Wereszczynski, Sung Wook Yi, et al.. (2014). Structural and Computational Studies of the Staphylococcus aureus Sortase B-Substrate Complex Reveal a Substrate-stabilized Oxyanion Hole. Journal of Biological Chemistry. 289(13). 8891–8902. 37 indexed citations

12.

Balaji, Kavitha, Daniel L. Clemens, Gang Deng, et al.. (2013). Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proceedings of the National Academy of Sciences. 110(50). E4904–12. 71 indexed citations

13.

Janzen, Deanna M., Daniel Y. Paik, Miguel A. Rosales, et al.. (2013). Low Levels of Circulating Estrogen Sensitize PTEN-Null Endometrial Tumors to PARP Inhibition In Vivo. Molecular Cancer Therapeutics. 12(12). 2917–2928. 22 indexed citations

14.

Johnson, Jared S., Vicente Meliton, Woo Kyun Kim, et al.. (2011). Novel oxysterols have pro‐osteogenic and anti‐adipogenic effects in vitro and induce spinal fusion in vivo. Journal of Cellular Biochemistry. 112(6). 1673–1684. 63 indexed citations

15.

Vigant, Frédéric, Michael E. Jung, & Benhur Lee. (2010). Positive Reinforcement for Viruses. Chemistry & Biology. 17(10). 1049–1051. 11 indexed citations

16.

Tran, Chris, Samedy Ouk, Nicola J. Clegg, et al.. (2009). Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer. Science. 324(5928). 787–790. 1689 indexed citations breakdown →

17.

Suree, Nuttee, Sung Wook Yi, William Thieu, et al.. (2009). Discovery and structure–activity relationship analysis of Staphylococcus aureus sortase A inhibitors. Bioorganic & Medicinal Chemistry. 17(20). 7174–7185. 94 indexed citations

18.

Duncan, Mara C., David Ho, Jing Huang, Michael E. Jung, & Gregory S. Payne. (2007). Composite synthetic lethal identification of membrane traffic inhibitors. Proceedings of the National Academy of Sciences. 104(15). 6235–6240. 17 indexed citations

19.

Jung, Michael E., Jeremy J. Clemens, Nuttee Suree, et al.. (2005). Synthesis of (2R,3S) 3-amino-4-mercapto-2-butanol, a threonine analogue for covalent inhibition of sortases. Bioorganic & Medicinal Chemistry Letters. 15(22). 5076–5079. 27 indexed citations

20.

Connolly, Kevin M., Brenton T. Smith, Rosemarie Pilpa, et al.. (2003). Sortase from Staphylococcus aureus Does Not Contain a Thiolate-Imidazolium Ion Pair in Its Active Site. Journal of Biological Chemistry. 278(36). 34061–34065. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact